National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 8) – specification under subsection 84AAA(2) (PB 92 of 2014)

Link to law: https://www.comlaw.gov.au/Details/F2014L01608

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
PB 92 of 2014
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 8) – specification under subsection 84AAA(2)
 
National Health Act 1953
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 25 November 2014
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
___________________________________________________________________________
 
Amendment determination – Pharmaceutical Benefits – Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 8) – specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as PB 92 of 2014.
 
2          Commencement
 
This Instrument commences on 1 December 2014.
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
 
 
Schedule 1        Amendments
 
[1]           Schedule 1, after entry for Enalapril with Hydrochlorothiazide
insert:
Enzalutamide
Capsule 40 mg
Oral
112
2
 
[2]           Schedule 1, after entry for Triptorelin
insert:
Umeclidinium
Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses
Inhalation by mouth
1
5
 

Umeclidinium with vilanterol
Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses
Inhalation by mouth
1
5